Antibody to histone H4, a core histone protein – modifications are crucial for chromatin organization and transcriptional regulation relevant to cancer.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162416 |
|---|---|
| Research Fields: | Epigenetics and Nuclear signalling |
| Application: | ELISA, WB, immunoprecipitation |
| Target: | Histone H4 |
| Reactivity: | Sequence conserved in wide range of species |
| Clone: | 3HH4-4G8 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Antibody to histone H4, a core histone protein – modifications are crucial for chromatin organization and transcriptional regulation relevant to cancer. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, k |
| Immunogen: | synthetic peptide: MSGRGKGGKGLGKGGAKRHRKVLR-(C) corresponding to aa 1 to 24 of human histone H4. |
| Target background: | Histone H4 is a core histone protein, and its modifications are crucial for chromatin organization and transcriptional regulation relevant to cancer. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151035 | Anti-CD8 [14] mAb |
Key Info
Anti-CD8 [14] mAb
|
View Tool | |||||||||||||||||||
| 151039 | Anti-Integrin aVb3 [23C6] |
Key Info
Anti-Integrin aVb3 [23C6]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.